NCT06732388 2026-04-13
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
11 trialsNCT05107219 2026-04-07
GCC Agonist Signal in the Small Intestine
University of Wisconsin, Madison
Phase 1 Completed
NCT00587314 2026-03-11
ablation IN BE
Mayo Clinic
Enrolling by invitation
NCT03835663 2024-03-26
The Bacterial Composition of the Stomach in Reflux Disease
Imperial College London
Unknown
NCT02560623 2022-11-17
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
Mayo Clinic
Phase NA Completed
NCT02699060 2022-02-18
Experimental Study to Determine the Effects of Human Refluxate on Macrophage Phenotype and Its Correlation With GERD
I.M. Sechenov First Moscow State Medical University
Phase NA Completed
NCT02922049 2020-02-18
pCLE in the Detection of Esophageal and Gastric Lesions and Intestinal Metaplasia or Dysplasia in Patients After Endoscopic Treatment of BORN
Institute for Clinical and Experimental Medicine
Phase NA Completed
NCT00586989 2016-01-07
ETMI
Mayo Clinic
Completed
NCT00566800 2013-09-17
Erlotinib in Treating Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 1 Unknown
NCT01209013 2012-05-08
Oedisse
Pinnacle Biologics Inc.
Phase 3 Withdrawn
NCT01442506 2011-09-28
Acetic Acid Guided Biopsies Compared With High Definition Endoscopy in the Detection of Barrett's Esophagus
Johannes Gutenberg University Mainz
Unknown